Cancer Cell

Journal

Publication Venue For

  • p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.  35:204-220.e9. 2019
  • Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.  34:211-224.e6. 2018
  • Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors.  34:119-135.e10. 2018
  • BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation.  33:1004-1016.e5. 2018
  • A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.  33:690-705.e9. 2018
  • Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.  33:721-735.e8. 2018
  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy.  33:676-689.e3. 2018
  • lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer.  33:706-720.e9. 2018
  • MST4 Phosphorylation of ATG4B Regulates Autophagic Activity, Tumorigenicity, and Radioresistance in Glioblastoma.  32:840-855.e8. 2017
  • Intertumoral Heterogeneity within Medulloblastoma Subgroups.  31:737-754.e6. 2017
  • Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer.  31:532-548.e7. 2017
  • Erratum: Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer (Cancer Cell (2017) 31(4) (532–548.e7)(S1535610817300600)(10.1016/j.ccell.2017.02.017)).  31:844-847. 2017
  • Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.  30:891-908. 2016
  • Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development.  30:92-107. 2016
  • Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.  29:201-213. 2016
  • Spleen Tyrosine Kinase Confers Paclitaxel Resistance in Ovarian Cancer.  28:7-9. 2015
  • Treatment of Chronic Myelogenous Leukemia by Blocking Cytokine Alterations Found in Normal Stem and Progenitor Cells.  27:671-681. 2015
  • Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia.  25:257. 2014
  • Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia.  24:575-588. 2013
  • The Role of Cdk5 in Neuroendocrine Thyroid Cancer.  24:499-511. 2013
  • Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma.  24:331-346. 2013
  • Erratum to The E3Ubiquitin Ligase Siah2 Contributes to Castration-Resistant Prostate Cancer by Regulation of Androgen Receptor Transcriptional Activity [Cancer Cell 23, (2013) 332-346].  23:853. 2013
  • Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells.  23:839-852. 2013
  • Erratum to Mechanistic rationale for inhibition of poly(ADP-Ribose) polymerase in ETS gene fusion-positive prostate cancer [Cancer Cell, 19 (2011) 664-678].  23:557. 2013
  • Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF.  23:302-315. 2013
  • The E3 ubiquitin ligase siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.  23:332-346. 2013
  • ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression.  22:180-193. 2012
  • Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia.  21:577-592. 2012
  • Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib.  21:266-281. 2012
  • Aurora Kinase-A Inactivates DNA Damage-Induced Apoptosis and Spindle Assembly Checkpoint Response Functions of p73.  21:196-211. 2012
  • Altered Hematopoietic Cell Gene Expression Precedes Development of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia and Identifies Patients at Risk.  20:591-605. 2011
  • Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer.  20:187-199. 2011
  • Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation.  20:11-24. 2011
  • Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer.  19:664-678. 2011
  • Nonreceptor Tyrosine Kinase BMX Maintains Self-Renewal and Tumorigenic Potential of Glioblastoma Stem Cells by Activating STAT3.  19:498-511. 2011
  • JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation.  19:283-294. 2011
  • Regulation of tumor angiogenesis by EZH2.  18:185-197. 2010
  • An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression.  17:443-454. 2010
  • Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate.  17:427-442. 2010
  • SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress.  17:41-52. 2010
  • A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2.  16:521-532. 2009
  • Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate..  16:336-346. 2009
  • Tumor Suppression by Phospholipase C-β3 via SHP-1-Mediated Dephosphorylation of Stat5.  16:161-171. 2009
  • Proteasomal and Genetic Inactivation of the NF1 Tumor Suppressor in Gliomagenesis.  16:44-54. 2009
  • Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells.  15:501-513. 2009
  • The Role of SPINK1 in ETS Rearrangement-Negative Prostate Cancers.  13:519-528. 2008
  • BMPing Off Glioma Stem Cells.  13:3-4. 2008
  • Integrative Genomics Analysis Reveals Silencing of β-Adrenergic Signaling by Polycomb in Prostate Cancer.  12:419-431. 2007
  • Rewired ERK-JNK Signaling Pathways in Melanoma.  11:447-460. 2007
  • Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.  8:393-406. 2005
  • Lost in translation: Dysregulation of cap-dependent translation and cancer.  5:519-523. 2004
  • Cancer therapeutics in yeast.  2:267-273. 2002
  • Positron emission tomography imaging analysis of G2A as a negative modifier of lymphoid leukemogenesis initiated by the BCR-ABL oncogene.  1:381-391. 2002
  • International Standard Serial Number (issn)

  • 1535-6108
  • Electronic International Standard Serial Number (eissn)

  • 1878-3686